Not checkedNot checked for notices yet.
Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
Andre K. Johnson, Zeron Ghazarian, Kristina D. Cendrowski and 1 more
Medical Mycology Case Reports · 2021
doi:10.1016/j.mmcr.2021.03.006 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, especially among critically ill patients. We report the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU.
Abstract licence: CC BY-NC-ND
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.